1. Home
  2. ATNM vs BRFH Comparison

ATNM vs BRFH Comparison

Compare ATNM & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.17

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Logo Barfresh Food Group Inc.

BRFH

Barfresh Food Group Inc.

HOLD

Current Price

$2.33

Market Cap

38.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNM
BRFH
Founded
2000
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
42.0M
38.7M
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
ATNM
BRFH
Price
$1.17
$2.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$4.50
$6.00
AVG Volume (30 Days)
108.9K
6.9K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
14.17
10.53
EPS
N/A
N/A
Revenue
$90,000.00
$211,467.00
Revenue This Year
N/A
$115.22
Revenue Next Year
N/A
$16.91
P/E Ratio
N/A
N/A
Revenue Growth
11.11
92.09
52 Week Low
$0.95
$2.25
52 Week High
$1.95
$6.08

Technical Indicators

Market Signals
Indicator
ATNM
BRFH
Relative Strength Index (RSI) 45.36 41.80
Support Level $0.99 $2.25
Resistance Level $1.25 $2.53
Average True Range (ATR) 0.07 0.11
MACD -0.01 0.00
Stochastic Oscillator 8.70 33.98

Price Performance

Historical Comparison
ATNM
BRFH

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About BRFH Barfresh Food Group Inc.

Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.

Share on Social Networks: